A closer look at the technologies used by Skyepharma Production SAS
Skyepharma Production SAS
Manufacturing · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
55 Rue Du Montmurier, Saint-Quentin-Fall...Phone Number
+33 474952020Website
www.skyepharma.comRevenue
$136.6 MillionIndustry
About Skyepharma Production SAS
Skyepharma is a French independent CDMO specializing in complex oral solid forms and highly potent APIs. They offer a comprehensive range of services from formulation development to industrial production, focusing on orphan drugs and innovative pharmaceutical solutions. With over 25 years of expertise, they cater to clients in biotechnology and pharmaceuticals, providing tailored support for clinical and commercial production. Their facilities comply with cGMP standards, enabling them to deliver high-quality products to over 160 countries.Explore more
SIC Code 28,283NAICS Code 32,325Show moreCompare Similar Companies to Skyepharma Production SAS
Compare insights from companies similar to Skyepharma Production SAS, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Skyepharma Production SAS
$136.6M
51-200
Private
-
1996
N/A
$12.9M
201-500
Private
-
1994
SB
Sarah BaischAnalytical QC, Stability & Micro Associate Director, Quality Control
Skyepharma Production SAS Tech Stack
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Skyepharma Production SAS
Sign Up For FreeTo access detailed company insights
Skyepharma is a French independent CDMO specializing in complex oral solid forms and highly potent APIs. They offer a comprehensive range of services from formulation development to industrial production, focusing on orphan drugs and innovative pharmaceutical solutions. With over 25 years of expertise, they cater to clients in biotechnology and pha... Read More